CHELMSFORD, Mass., July 16 /PRNewswire/ -- Magellan Biosciences, an emerging leader in clinical diagnostics, will feature a variety of automated systems and diagnostic tests designed to help doctors make faster, more-informed treatment decisions in Booth 3244 at the 2009 AACC/ASCLS Clinical Lab Expo. Products on view will include TREK's blood-culture systems and susceptibility products; Dynex's automated ELISA assay systems; ESA's FDA-cleared Vitamin D Test; and the LeadCare(R) II three-minute blood-lead test. The Clinical Lab Expo runs from July 21 to 23 at The McCormick Place Convention Center in Chicago.
"The recent healthcare-reform debate has included a focus on the importance of quality and 'outcomes-based' treatment -- and diagnostics will no doubt be at the center of discussions going forward," said Magellan President and Chief Executive Officer, Robert J. Rosenthal, Ph.D. "Better diagnostics lead to more-informed treatment decisions and superior care. Clinicians, healthcare executives, and lab managers alike recognize that more-efficient and easier-to-use diagnostic tools like the ones we offer under the TREK, Dynex, ESA, and LeadCare names are central to maximizing productivity of overburdened lab staff, realizing cost savings, and improving health outcomes."
TREK Diagnostic Systems will demonstrate automated systems that address the growing problem of antimicrobial-resistant organisms.
For more information on TREK products, visit www.trekds.com.
Dynex Technologies will feature demonstrations of the DS2(R) two-plate and DSX(R) four-plate ELISA processing systems. Designed for efficiency and reliability with the 'expert' inside, they perform the most-sophisticated analyses, but are easy to use for operators with varying levels of education and experience. The DSX and DS2 are open systems with full walk-away automation and precise liquid-handling capabilities. They execute the entire complement of analytical steps required for virtually any ELISA immunoassay: adding samples and reagents, washing, incubation, and detection, delivering all you need to ensure the rigorous, repeatable analyses required in critical applications -- from immunology to infectious disease, hormone, allergy, blood-chemistry, and drugs-of-abuse testing. To see a video of the DS2 at work, visit www.dynextechnologies.com.
ESA Life Sciences will feature its FDA-cleared test to assess vitamin D sufficiency, a practical, cost-effective alternative to send-out tests that offers significant improvements over other methodologies. The ESA Biosciences Vitamin D Test, comprising reagent kit and test system, detects each form of vitamin D individually and automatically reports total 25(OH)D, with none of the antibody or protein-binding specificity issues associated with existing assays. The ESA test provides accurate and specific results as demonstrated through comparison with other methods (HPLC-UV and LC-MS), offering simplified extraction and lower sample-volume requirements. The ESA assay is reimbursable (CPT code 82306). To view a video demonstration of the ESA Vitamin D test, visit www.esainc.com/products/markets/clinical_diagnostics/vit_d.
LeadCare - Magellan will also feature its showcase LeadCare II blood-lead-testing system, which has been used successfully around the world as a point-of-care test and in clinical-laboratory settings. Because traditional prescription-based and send-out practices have missed those children most at-risk for lead poisoning, policy-makers at the federal, state, and local level are taking action to encourage the use of LeadCare II to ensure that children receive mandated testing. In 2009, the National Committee for Quality Assurance (NCQA) added completion of blood-lead testing as one of the Healthcare Effectiveness Data and Information Set (HEDIS) measures it uses for rating the quality of health plans. Consequently, many health plans and providers are turning to the point-of-care test to help boost screening rates and improve their HEDIS report cards.
For important lead-poisoning prevention resources, links to consumer product recall information, and tips for keeping children safe, visit www.LeadPoisonInfo.com.
About Magellan Biosciences (www.magellanbio.com)
An emerging leader in clinical-diagnostic markets for hospital-based labs and near-patient testing, Magellan serves the worldwide clinical-diagnostic market with rapid point-of-care analyzers and consumables; blood culture, susceptibility systems, and reagents for microbiology labs; automated ELISA assay processing systems; esoteric assays; and services. Scientists use our life-science tools for cutting-edge research to develop a new understanding of health and illness, for drug development, and for quality assurance/quality control applications. We design all our products to deliver better, more-reliable results. And better results help drive improved health outcomes: earlier, more-accurate diagnoses, breakthroughs that can lead to novel treatments, new cures -- innovations to enhance life. Magellan brands include LeadCare, ESA, Dynex, and TREK.
|SOURCE Magellan Biosciences|
Copyright©2009 PR Newswire.
All rights reserved